Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.

Martin HJ, Lee JM, Walls D, Hayward SD.

J Virol. 2007 Sep;81(18):9748-58. Epub 2007 Jul 3.

2.

Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.

Cavalcante P, Galbardi B, Franzi S, Marcuzzo S, Barzago C, Bonanno S, Camera G, Maggi L, Kapetis D, Andreetta F, Biasiucci A, Motta T, Giardina C, Antozzi C, Baggi F, Mantegazza R, Bernasconi P.

Immunobiology. 2016 Apr;221(4):516-27. doi: 10.1016/j.imbio.2015.12.007. Epub 2015 Dec 12.

PMID:
26723518
3.

EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.

Le Clorennec C, Youlyouz-Marfak I, Adriaenssens E, Coll J, Bornkamm GW, Feuillard J.

Blood. 2006 Mar 1;107(5):2070-8. Epub 2005 Nov 29.

4.

Interferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation.

Xu D, Meyer F, Ehlers E, Blasnitz L, Zhang L.

J Biol Chem. 2011 May 20;286(20):18261-7. doi: 10.1074/jbc.M110.210542. Epub 2011 Mar 24.

5.

Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.

Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E.

J Virol. 2004 Apr;78(8):4108-19.

6.

Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes.

Xu D, Zhao L, Del Valle L, Miklossy J, Zhang L.

J Virol. 2008 Jul;82(13):6251-8. doi: 10.1128/JVI.00163-08. Epub 2008 Apr 16.

7.

TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.

Greenfeld H, Takasaki K, Walsh MJ, Ersing I, Bernhardt K, Ma Y, Fu B, Ashbaugh CW, Cabo J, Mollo SB, Zhou H, Li S, Gewurz BE.

PLoS Pathog. 2015 May 21;11(5):e1004890. doi: 10.1371/journal.ppat.1004890. eCollection 2015 May.

8.

Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.

Vrazo AC, Chauchard M, Raab-Traub N, Longnecker R.

PLoS Pathog. 2012;8(4):e1002662. doi: 10.1371/journal.ppat.1002662. Epub 2012 Apr 19.

9.

Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.

Smith N, Tierney R, Wei W, Vockerodt M, Murray PG, Woodman CB, Rowe M.

PLoS One. 2013 May 27;8(5):e64868. doi: 10.1371/journal.pone.0064868. Print 2013.

10.

A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.

Martorelli D, Muraro E, Mastorci K, Dal Col J, Faè DA, Furlan C, Giagulli C, Caccuri F, Rusnati M, Fiorentini S, Carbone A, Caruso A, Dolcetti R.

Int J Cancer. 2015 Sep 15;137(6):1374-85. doi: 10.1002/ijc.29494. Epub 2015 Mar 9.

11.

Epstein Barr virus inhibits the stimulatory effect of TLR7/8 and TLR9 agonists but not CD40 ligand in human B lymphocytes.

Younesi V, Nikzamir H, Yousefi M, Khoshnoodi J, Arjmand M, Rabbani H, Shokri F.

Microbiol Immunol. 2010 Sep;54(9):534-41. doi: 10.1111/j.1348-0421.2010.00248.x.

12.
13.

Inhibition of cell growth and Epstein-Barr virus reactivation by CD40 stimulation in Epstein-Barr virus-transformed B cells.

Fukuda M, Satoh TA, Takanashi M, Hirai K, Ohnishi E, Sairenji T.

Viral Immunol. 2000;13(2):215-29.

PMID:
10893001
14.

The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.

Forte E, Salinas RE, Chang C, Zhou T, Linnstaedt SD, Gottwein E, Jacobs C, Jima D, Li QJ, Dave SS, Luftig MA.

J Virol. 2012 Jun;86(12):6889-98. doi: 10.1128/JVI.07056-11. Epub 2012 Apr 11.

15.

The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7.

Ning S, Pagano JS.

J Virol. 2010 Jun;84(12):6130-8. doi: 10.1128/JVI.00364-10. Epub 2010 Apr 14.

16.

Dual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytes.

Zhao Y, Xu D, Jiang Y, Zhang L.

PLoS One. 2010 Mar 4;5(3):e9459. doi: 10.1371/journal.pone.0009459.

17.

Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression.

Wang L, Toomey NL, Diaz LA, Walker G, Ramos JC, Barber GN, Ning S.

J Virol. 2011 Aug;85(16):8328-37. doi: 10.1128/JVI.00570-11. Epub 2011 Jun 15.

18.
19.

c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.

Faumont N, Durand-Panteix S, Schlee M, Grömminger S, Schuhmacher M, Hölzel M, Laux G, Mailhammer R, Rosenwald A, Staudt LM, Bornkamm GW, Feuillard J.

J Virol. 2009 May;83(10):5014-27. doi: 10.1128/JVI.02264-08. Epub 2009 Mar 4.

20.

LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.

Bentz GL, Moss CR 2nd, Whitehurst CB, Moody CA, Pagano JS.

J Virol. 2015 Aug;89(15):7465-77. doi: 10.1128/JVI.00711-15. Epub 2015 May 6.

Supplemental Content

Support Center